We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$8.34M
Cap. Flow
-$2.14M
Cap. Flow %
-0.89%
Top 10 Hldgs %
31.13%
Holding
156
New
16
Increased
22
Reduced
90
Closed
5

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.17M
2
ABT icon
Abbott
ABT
+$1.04M
3
TGT icon
Target
TGT
+$910K
4
XYL icon
Xylem
XYL
+$837K
5
XLNX
Xilinx Inc
XLNX
+$764K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$4.32M
2
ILMN icon
Illumina
ILMN
+$1.7M
3
PEP icon
PepsiCo
PEP
+$1.4M
4
NXPI icon
NXP Semiconductors
NXPI
+$668K
5
CVS icon
CVS Health
CVS
+$600K

Sector Composition

Rank Sector Weight
1 Technology 24.27%
2 Healthcare 21.64%
3 Industrials 17.46%
4 Energy 11.72%
5 Miscellaneous 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$119B
$8.47M 3.53%
112,316
-7,945
-7% -$600K
JNJ icon
2
Johnson & Johnson
JNJ
$646B
$8.28M 3.46%
79,110
-1,600
-2% -$162K
CNI icon
3
Canadian National Railway
CNI
$76.2B
$8.16M 3.4%
125,440
-3,600
-3% -$214K
NVS icon
4
Novartis
NVS
$292B
$8.13M 3.4%
100,284
-4,369
-4% -$344K
EMR icon
5
Emerson Electric
EMR
$86.6B
$7.34M 3.07%
110,655
-2,350
-2% -$158K
MA icon
6
Mastercard
MA
$521B
$6.74M 2.81%
91,730
-4,210
-4% -$313K
MMM icon
7
3M
MMM
$89.9B
$6.69M 2.79%
55,821
-706
-1% -$82.9K
PG icon
8
Procter & Gamble
PG
$334B
$6.65M 2.78%
84,646
-2,470
-3% -$199K
AAPL icon
9
Apple
AAPL
$4.67T
$6.5M 2.71%
279,664
-3,724
-1% -$79.2K
ADP icon
10
Automatic Data Processing
ADP
$114B
$6.16M 2.57%
88,534
+2,705
+3% +$185K
ATR icon
11
AptarGroup
ATR
$8.46B
$5.99M 2.5%
89,390
-870
-1% -$57.8K
SLB icon
12
SLB Ltd
SLB
$85.1B
$5.92M 2.47%
50,205
+190
+0.4% +$19.6K
ORCL icon
13
Oracle
ORCL
$435B
$5.6M 2.34%
138,254
-3,475
-2% -$143K
XOM icon
14
ExxonMobil
XOM
$644B
$5.54M 2.31%
55,040
-1,805
-3% -$182K
CVX icon
15
Chevron
CVX
$396B
$5.5M 2.29%
42,101
+100
+0.2% +$12.4K
EMC
16
DELISTED
EMC CORPORATION
EMC
$5.39M 2.25%
204,708
-4,000
-2% -$106K
INTC icon
17
Intel
INTC
$473B
$5.24M 2.19%
169,621
-5,525
-3% -$151K
PEP icon
18
PepsiCo
PEP
$193B
$5.06M 2.11%
56,609
-16,216
-22% -$1.4M
QCOM icon
19
Qualcomm
QCOM
$175B
$4.89M 2.04%
61,745
+14,730
+31% +$1.17M
ROK icon
20
Rockwell Automation
ROK
$47.8B
$4.87M 2.03%
38,929
+484
+1% +$59.6K
FISV
21
Fiserv Inc
FISV
$28.3B
$4.78M 2%
158,550
+5,130
+3% +$152K
HP icon
22
Helmerich & Payne
HP
$4.25B
$4.67M 1.95%
40,195
+2,020
+5% +$221K
PBA icon
23
Pembina Pipeline
PBA
$27.9B
$4.31M 1.8%
100,290
+950
+1% +$38.1K
RTX icon
24
RTX Corp
RTX
$285B
$4.27M 1.78%
58,723
+6,483
+12% +$477K
JCI icon
25
Johnson Controls International
JCI
$84.6B
$4.17M 1.74%
79,680
+2,253
+3% +$112K
1
2 3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q2 2014 Portfolio in Review

As of Q2 2014, Michael B. Elefante held 156 positions worth $240M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael B. Elefante's Q2 2014 filing shows 16 new, 22 increased, 90 reduced and 5 closed positions. Its largest new stake was Xylem: 22,405 shares worth $875K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $4.32M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Michael B. Elefante's largest Q2 2014 buy was Xylem: 22,405 shares worth $875K.
  • Michael B. Elefante added most to Qualcomm in Q2 2014, an estimated $1.17M increase.
  • Michael B. Elefante's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $4.32M.
  • Michael B. Elefante fully exited Aflac in Q2 2014, selling an estimated $91K.
  • Michael B. Elefante's ten largest holdings make up 31% of its $240M portfolio in Q2 2014.
  • Michael B. Elefante opened 16 new positions and closed 5 in Q2 2014.
  • Michael B. Elefante's portfolio value rose 3.6% quarter-over-quarter to $240M.

Based on Michael B. Elefante's 13F filing for Q2 2014, filed 24 Jul 2014.